Allworth Financial LP Volitionrx LTD Transaction History
Allworth Financial LP
- $16.1 Billion
- Q3 2024
A detailed history of Allworth Financial LP transactions in Volitionrx LTD stock. As of the latest transaction made, Allworth Financial LP holds 200 shares of VNRX stock, worth $120. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 200
-0.0%
Holding current value
$120
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding VNRX
# of Institutions
26Shares Held
17.8MCall Options Held
41KPut Options Held
100-
Armistice Capital, LLC New York, NY9MShares$5.4 Million0.09% of portfolio
-
Lagoda Investment Management, L.P. New York, NY6.1MShares$3.66 Million2.11% of portfolio
-
Geode Capital Management, LLC Boston, MA730KShares$438,2680.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA637KShares$382,0000.0% of portfolio
-
Black Rock Inc. New York, NY516KShares$309,6430.0% of portfolio
About VOLITIONRX LTD
- Ticker VNRX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 57,297,000
- Market Cap $34.4M
- Description
- VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...